Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance

N Erin, J Grahovac, A Brozovic, T Efferth - Drug Resistance Updates, 2020 - Elsevier
It is well established that multifactorial drug resistance hinders successful cancer treatment.
Tumor cell interactions with the tumor microenvironment (TME) are crucial in epithelial …

Autophagy and multidrug resistance in cancer

YJ Li, YH Lei, N Yao, CR Wang, N Hu, WC Ye… - Chinese journal of …, 2017 - Springer
Multidrug resistance (MDR) occurs frequently after long-term chemotherapy, resulting in
refractory cancer and tumor recurrence. Therefore, combatting MDR is an important issue …

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

X Sui, R Chen, Z Wang, Z Huang, N Kong… - Cell death & …, 2013 - nature.com
Induction of cell death and inhibition of cell survival are the main principles of cancer
therapy. Resistance to chemotherapeutic agents is a major problem in oncology, which …

Targeting the PI3K/AKT/mTOR pathway in bladder cancer

A Sathe, R Nawroth - Urothelial carcinoma: Methods and protocols, 2018 - Springer
Abstract The PI3K/AKT/mTOR signaling pathway shows frequent molecular alterations and
increased activity in cancer. Given its role in the regulation of cell growth, survival and …

Autophagy as a pro‐death pathway

D Denton, T Xu, S Kumar - Immunology and cell biology, 2015 - Wiley Online Library
The evolutionarily conserved catabolic process of autophagy involves the degradation of
cytoplasmic components through lysosomal enzymes. Basal levels of autophagy maintain …

[HTML][HTML] PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth

N Sharma, R Nanta, J Sharma, S Gunewardena… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Cancer stem cells (CSCs) play major roles in cancer initiation, progression, and metastasis.
It is evident from growing reports that PI3K/Akt/mTOR and Sonic Hedgehog (Shh) signaling …

Research progress of traditional Chinese medicine monomers in reversing multidrug resistance of breast cancer

S Wang, S Yang, X Yang, D Deng, J Li… - The American Journal of …, 2023 - World Scientific
Breast cancer is a malignant disease with an increasing incidence. Chemotherapy is still an
important means for breast cancer treatment, but multidrug resistance (MDR) greatly limits its …

The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer

KT Jin, ZB Lu, JQ Lv, JG Zhang - RNA biology, 2020 - Taylor & Francis
Cancer is a complex process in which protein-coding and non-coding genes play essential
roles. Long noncoding RNAs (lncRNAs), as a subclass of noncoding genes, are implicated …

[HTML][HTML] Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex

D Schluetermann, MA Skowron, N Berleth… - … Oncology: Seminars and …, 2018 - Elsevier
Background Cisplatin-based regimens are routinely employed for the treatment of urothelial
carcinoma. However, therapeutic success is hampered by the primary presence of or the …

Nanomaterial-induced autophagy: a new reversal MDR tool in cancer therapy?

E Panzarini, L Dini - Molecular Pharmaceutics, 2014 - ACS Publications
Most of the therapeutic strategies to counteract cancer imply killing of malignant cells. The
most exploited cell death mechanism in cancer therapies is apoptosis, but recently, a lot of …